Litcius/Paper detail

First CAR-T therapy to target BCMA gets FDA nod

Unknown authors

2021Nature Biotechnology15 citationsDOI

Topics & Concepts

NodCAR T-cell therapyMedicineVirologyComputational biologyImmunologyBiologyChimeric antigen receptorGeneticsT cellGeneImmune systemBiomedical Ethics and RegulationBiosimilars and Bioanalytical MethodsCAR-T cell therapy research
First CAR-T therapy to target BCMA gets FDA nod | Litcius